Short‐term mortality (30‐day or in‐hospital) · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in short‐term mortality (30‐day or in‐hospital) compared with cut‐down femoral artery access (low certainty).
1 finding from 1 review
Failure of aneurysm exclusion ( · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in failure of aneurysm exclusion( compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review
Wound infection · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in wound infection (30‐day or in‐hospital) compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review
Major complications · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in major complications (30‐day or in‐hospital) compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review
Medium‐ to long‐term complications( · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in medium‐ to long‐term complications( compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review
Bleeding complications (30‐day or in‐hospital) · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in bleeding complications (30‐day or in‐hospital) compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review
Operating time · people undergoing elective bifurcated abdominal endovascular aneurysm repair
1 finding from 1 review
Operating time · treating kidney stones
1 finding from 1 review
Length of hospital stay · treating kidney stones
1 finding from 1 review
Blood transfusion · treating kidney stones
It is very uncertain whether totally tubeless PNL changes blood transfusion MCID: 10 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Sepsis or fever MCID: 50 per 1000 · treating kidney stones
Totally tubeless PNL showed no clear difference in sepsis or fever MCID: 50 per 1000 compared with standard PNL (low certainty).
1 finding from 1 review
Patient readmissions · treating kidney stones
1 finding from 1 review
Severe adverse events MCID: 50 per 1000 · treating kidney stones
Totally tubeless PNL showed no clear difference in severe adverse events MCID: 50 per 1000 compared with standard PNL (low certainty).
1 finding from 1 review
Postoperative pain (day 1) · treating kidney stones
1 finding from 1 review
Severe adverse events MCID: 50 per 1000 · treating kidney stones
It is very uncertain whether tubeless PNL changes severe adverse events MCID: 50 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Postoperative pain (day 1) · treating kidney stones
1 finding from 1 review
Operating time · treating kidney stones
1 finding from 1 review
Length of hospital stay · treating kidney stones
1 finding from 1 review
Blood transfusion · treating kidney stones
It is very uncertain whether tubeless PNL changes blood transfusion MCID: 10 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Sepsis or fever MCID: 50 per 1000 · treating kidney stones
It is very uncertain whether tubeless PNL changes sepsis or fever MCID: 50 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review